212 related articles for article (PubMed ID: 32978989)
1. Oligonucleotide-Based Therapeutics: An Emerging Strategy for the Treatment of Chronic Liver Diseases.
Alkhouri N; Reddy GK; Lawitz E
Hepatology; 2021 Apr; 73(4):1581-1593. PubMed ID: 32978989
[No Abstract] [Full Text] [Related]
2. Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?
Kim KH; Park KK
World J Gastroenterol; 2014 Oct; 20(40):14696-705. PubMed ID: 25356032
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic oligonucleotides.
Goodchild J
Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
[TBL] [Abstract][Full Text] [Related]
4. Oligonucleotide-based therapy for neurodegenerative diseases.
Magen I; Hornstein E
Brain Res; 2014 Oct; 1584():116-28. PubMed ID: 24727531
[TBL] [Abstract][Full Text] [Related]
5. RNA-targeted therapeutics in cancer clinical trials: Current status and future directions.
Barata P; Sood AK; Hong DS
Cancer Treat Rev; 2016 Nov; 50():35-47. PubMed ID: 27612280
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer.
Takakura K; Kawamura A; Torisu Y; Koido S; Yahagi N; Saruta M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284594
[TBL] [Abstract][Full Text] [Related]
7. Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases.
Mehta M; Deeksha ; Tewari D; Gupta G; Awasthi R; Singh H; Pandey P; Chellappan DK; Wadhwa R; Collet T; Hansbro PM; Kumar SR; Thangavelu L; Negi P; Dua K; Satija S
Chem Biol Interact; 2019 Aug; 308():206-215. PubMed ID: 31136735
[TBL] [Abstract][Full Text] [Related]
8. RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases.
Germain ND; Chung WK; Sarmiere PD
Mol Aspects Med; 2023 Jun; 91():101148. PubMed ID: 36257857
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation.
Sun Y; Zhao Y; Zhao X; Lee RJ; Teng L; Zhou C
Molecules; 2017 Oct; 22(10):. PubMed ID: 29027965
[TBL] [Abstract][Full Text] [Related]
10. [Oligonucleotide therapeutics - an emerging novel class of compounds].
Wacheck V
Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
[TBL] [Abstract][Full Text] [Related]
11. The infinite possibilities of RNA therapeutics.
Mollocana-Lara EC; Ni M; Agathos SN; Gonzales-Zubiate FA
J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34463324
[TBL] [Abstract][Full Text] [Related]
12. RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases.
Bejar N; Tat TT; Kiss DL
Curr Atheroscler Rep; 2022 May; 24(5):307-321. PubMed ID: 35364795
[TBL] [Abstract][Full Text] [Related]
13. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
14. RNA-based therapeutics--from design to the clinic.
Iversen P
Curr Opin Mol Ther; 2009 Apr; 11(2):107. PubMed ID: 19330715
[No Abstract] [Full Text] [Related]
15. Non-coding RNAs: Therapeutic Strategies and Delivery Systems.
Ling H
Adv Exp Med Biol; 2016; 937():229-37. PubMed ID: 27573903
[TBL] [Abstract][Full Text] [Related]
16. Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases.
Liao W; Dong J; Peh HY; Tan LH; Lim KS; Li L; Wong WF
Molecules; 2017 Jan; 22(1):. PubMed ID: 28106744
[TBL] [Abstract][Full Text] [Related]
17. Nucleic Acid-Based Therapies for Atherosclerosis.
Mäkinen P; Ruotsalainen AK; Ylä-Herttuala S
Curr Atheroscler Rep; 2020 Feb; 22(2):10. PubMed ID: 32034521
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.
Kwekkeboom RF; Lei Z; Doevendans PA; Musters RJ; Sluijter JP
Clin Sci (Lond); 2014 Sep; 127(6):351-65. PubMed ID: 24895056
[TBL] [Abstract][Full Text] [Related]
19. Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses.
Spurgers KB; Sharkey CM; Warfield KL; Bavari S
Antiviral Res; 2008 Apr; 78(1):26-36. PubMed ID: 18258313
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA miR-122 as a therapeutic target for oligonucleotides and small molecules.
Thomas M; Deiters A
Curr Med Chem; 2013; 20(29):3629-40. PubMed ID: 23745562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
